Next Article in Journal
Optimizing Therapeutic Strategies for Syringomyelia Associated with Tethered Cord Syndrome: A Comprehensive Review
Previous Article in Journal
Improving Evidence-Synthesis for School-Based Obesity Prevention Interventions. Comment on Ginell et al. Unreliable Findings Due to Miscalculations and Errors. Comment on Nally et al. The Effectiveness of School-Based Interventions on Obesity-Related Behaviours in Primary School Children: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Children 2021, 8, 489. Children 2023, 10, 1660
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Case Report

Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report

by
Margherita Di Costanzo
1,*,
Nicoletta de Paulis
1,
Giuseppe Cannalire
1,
Nicola Morelli
2 and
Giacomo Biasucci
1,3
1
Pediatrics and Neonatology Unit, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy
2
Diagnostic Neuroradiology Unit, Department of Radiological Functions, Guglielmo da Saliceto Hospital, 29121 Piacenza, Italy
3
Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy
*
Author to whom correspondence should be addressed.
Children 2024, 11(8), 960; https://doi.org/10.3390/children11080960 (registering DOI)
Submission received: 3 July 2024 / Revised: 29 July 2024 / Accepted: 8 August 2024 / Published: 9 August 2024
(This article belongs to the Section Pediatric Neurology & Neurodevelopmental Disorders)

Abstract

We report on a 4-year-old boy affected by Gaucher disease (GD) type 3, who presented with splenomegaly and a history of oculomotor apraxia. GD is a rare lysosomal storage disorder caused by glucocerebrosidase deficiency with multi-organ involvement. Besides common clinical features such as hepatosplenomegaly and skeletal involvement, less frequent neurological symptoms, such as oculomotor apraxia, are indicative of neuronopathic forms of the disease, namely GD type 3, to be confirmed both by enzyme activity and genetic testing. Overall, GD management requires a multidisciplinary approach involving metabolic pediatricians, neurologists, psychologists, and geneticists, and currently relies on early enzyme replacement therapy. Although enzyme replacement therapy has proved to be effective in improving systemic signs and symptoms, it is unable to alleviate neurological complications once these have occurred, as it does not pass across the blood–brain barrier. Neurological improvements may occur through indirect mechanisms. Thus, our case report aims to highlight the importance of considering GD in the differential diagnosis of pediatric patients presenting with splenomegaly associated with neurological manifestations, as early intervention may significantly modify the disease progression and prevent further irreversible complications.
Keywords: lysosomal storage disorder; beta-glucocerebrosidase; enzyme replacement therapy; splenomegaly; inherited metabolic diseases lysosomal storage disorder; beta-glucocerebrosidase; enzyme replacement therapy; splenomegaly; inherited metabolic diseases

Share and Cite

MDPI and ACS Style

Di Costanzo, M.; de Paulis, N.; Cannalire, G.; Morelli, N.; Biasucci, G. Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report. Children 2024, 11, 960. https://doi.org/10.3390/children11080960

AMA Style

Di Costanzo M, de Paulis N, Cannalire G, Morelli N, Biasucci G. Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report. Children. 2024; 11(8):960. https://doi.org/10.3390/children11080960

Chicago/Turabian Style

Di Costanzo, Margherita, Nicoletta de Paulis, Giuseppe Cannalire, Nicola Morelli, and Giacomo Biasucci. 2024. "Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report" Children 11, no. 8: 960. https://doi.org/10.3390/children11080960

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop